{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:56:09Z","timestamp":1759010169024},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,9,1]]},"DOI":"10.1086\/314037","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T14:58:36Z","timestamp":1027695516000},"page":"826-829","source":"Crossref","is-referenced-by-count":26,"title":["Treatment of Latent Tuberculosis Infection in Patients Aged \u226535 Years"],"prefix":"10.1093","volume":"31","author":[{"given":"Shelley A.","family":"Gilroy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary A. M.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald C.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2000,9]]},"reference":[{"key":"key\n\t\t\t\t20171014004239_R1","first-page":"558","article-title":"Chemoprophylaxis for the prevention of tuberculosis: a statement by an ad hoc committee","volume":"96","author":"American Thoracic Society","year":"1967","journal-title":"Am Rev Respir Dis"},{"key":"key\n\t\t\t\t20171014004239_R2","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archinte.1977.03630210016007","article-title":"Isoniazid chemoprophylaxis: association with detection and incidence of liver toxicity","volume":"137","author":"Byrd","year":"1977","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171014004239_R3","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.7326\/0003-4819-71-6-1113","article-title":"Serum transaminase elevation and other hepatic abnormalities in patients receiving isoniazid","volume":"61","author":"Scharer","year":"1969","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171014004239_R4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1164\/arrd.1972.106.3.357","article-title":"Isoniazid associated hepatitis: report of an outbreak","volume":"106","author":"Garibaldi","year":"1972","journal-title":"Am Rev Respir Dis"},{"key":"key\n\t\t\t\t20171014004239_R5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-79-1-1","article-title":"Isoniazid hepatitis","volume":"79","author":"Maddrey","year":"1973","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171014004239_R6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0016-5085(19)32568-5","article-title":"Isoniazid associated hepatitis in 114 patients","volume":"69","author":"Black","year":"1975","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171014004239_R7","first-page":"371","article-title":"Preventive therapy of tuberculosis infection","volume":"110","year":"1974","journal-title":"Am Rev Respir Dis"},{"key":"key\n\t\t\t\t20171014004239_R8","first-page":"790","article-title":"Treatment of tuberculosis and other mycobacterial diseases","volume":"127","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"key\n\t\t\t\t20171014004239_R9","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1378\/chest.87.2_Supplement.128S","article-title":"Preventive treatment of tuberculosis","volume":"87","author":"Bailey","year":"1985","journal-title":"Chest"},{"key":"key\n\t\t\t\t20171014004239_R10","article-title":"National Center for Prevention Services Division of Tuberculosis Elimination","volume-title":"Core curriculum on tuberculosis","year":"1994","edition":"3d ed."},{"key":"key\n\t\t\t\t20171014004239_R11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1378\/chest.108.3.706","article-title":"Underutilization of isoniazid chemoprophylaxis in tuberculosis contacts 50 years of age and older: a prospective analysis","volume":"108","author":"Soresso","year":"1995","journal-title":"Chest"},{"key":"key\n\t\t\t\t20171014004239_R12","first-page":"545","article-title":"Severe isoniazid-associated hepatitis\u2014New York, 1991\u20131993","volume":"42","year":"1993","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171014004239_R13","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1164\/ajrccm\/144.6.1357","article-title":"Isoniazid preventive therapy for tuberculosis: decision analysis considering ethnicity and gender","volume":"144","author":"Jordan","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"key\n\t\t\t\t20171014004239_R14","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jama.281.11.1014","article-title":"Hepatotoxicity associated with isoniazid preventive therapy: a seven year survey from a public health tuberculosis clinic","volume":"281","author":"Nolan","year":"1999","journal-title":"JAMA"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/31\/3\/826\/20904627\/31-3-826.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:42:54Z","timestamp":1583282574000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/31\/3\/826\/299661\/Treatment-of-Latent-Tuberculosis-Infection-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9,1]]},"references-count":14,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2000,9]]},"published-print":{"date-parts":[[2000,9,1]]}},"URL":"https:\/\/doi.org\/10.1086\/314037","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2000,9]]},"published":{"date-parts":[[2000,9,1]]}}}